Inventor · disambiguated record
Aaron D. Schuler
Also filed as: SCHULER AARON · SCHULER AARON D
11 granted patents·1 pending application·50 citations·filing 2011–2024
89Inventor score
Top patents by PatentIndex Score
12 records- 0193US9707248B2Use of thiopyrimidinecarboxamide for treating cancerSYNTRIX BIOSYSTEMS INC·Filed 2016·Granted Jul 18, 2017·5 cites·24 claims
- 0293US9480694B2Thiopyrimidinecarboxamide for use in treating pulmonary diseaseSYNTRIX BIOSYSTEMS INC·Filed 2015·Granted Nov 1, 2016·6 cites·20 claims
- 0393US8969365B2Thiopyrimidinecarboxamides as CXCR1/2 modulatorsSYNTRIX BIOSYSTEMS INC·Filed 2013·Granted Mar 3, 2015·9 cites·17 claims
- 0491US10046002B2Method for treating cancer using chemokine antagonistsSYNTRIX BIOSYSTEMS INC·Filed 2016·Granted Aug 14, 2018·6 cites·22 claims
- 0588US8993541B2Aminopyrimidinecarboxamides as CXCR2 modulatorsSYNTRIX BIOSYSTEMS INC·Filed 2014·Granted Mar 31, 2015·9 cites·6 claims
- 0687US10130645B2Use of thiopyrimidinecarboxamide for treating cancerSYNTRIX BIOSYSTEMS INC·Filed 2017·Granted Nov 20, 2018·3 cites·20 claims
- 0786US8779149B2Aminopyridine- and aminopyrimidinecarboxamides as CXCR2 modulatorsMAEDA DEAN Y·Filed 2011·Granted Jul 15, 2014·9 cites·6 claims
- 0885US10660909B2Method for treating cancer using chemokine antagonistsSYNTRIX BIOSYSTEMS INC·Filed 2018·Granted May 26, 2020·2 cites·29 claims
- 0982US10993953B2Method for treating cancer using chemokine antagonistsSYNTRIX BIOSYSTEMS INC·Filed 2019·Granted May 4, 2021·1 cites·31 claims
- 1066USRE48547EAminopyrimidinecarboxamides as CXCR2 modulatorsSYNTRIX BIOSYSTEMS INC·Filed 2017·Granted May 11, 2021·0 cites·40 claims
- 1155USRE47740EAminopyridinecarboxamides as CXCR2 modulatorsSYNTRIX BIOSYSTEMS INC·Filed 2016·Granted Nov 26, 2019·0 cites·27 claims
- 1252US2025116216A1MufflerPurem GmbH·Filed 2024·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Aaron D. Schuler files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →